Delivery Order SPE2DB22D3016-SPE2DB25FBJW3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $6,007.38 delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price contract, with an ultimate completion date of July 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors with a ceiling value of $7,303.38 and a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 2, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $17,364.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $38,628.48 delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader relationship...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $8,359.40 and an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a ceiling value of $2,696.06. This is a firm fixed-price, non-set-aside delivery order with a completion date of June 3, 2025, with performance to be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,447.09 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999 billion through...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJW3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,143.87 and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier within the federal healthcare procurement ecosystem, particularly for military and veteran medical systems. As a major pharmaceutical distributor, the company fulfills federal demand across multiple therapeutic domains through its comprehensive prime vendor contract, which enables supply of specialty medications, brand-name and generic drugs, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare entities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/17/25 |